PTPRR Human Pre-designed siRNA Set A contains three designed siRNAs for PTPRR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPRS Human Pre-designed siRNA Set A contains three designed siRNAs for PTPRS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPRT Human Pre-designed siRNA Set A contains three designed siRNAs for PTPRT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPRU Human Pre-designed siRNA Set A contains three designed siRNAs for PTPRU gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTPRZ1 Human Pre-designed siRNA Set A contains three designed siRNAs for PTPRZ1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTRH1 Human Pre-designed siRNA Set A contains three designed siRNAs for PTRH1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTRH2 Human Pre-designed siRNA Set A contains three designed siRNAs for PTRH2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTS Human Pre-designed siRNA Set A contains three designed siRNAs for PTS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTTG1 Human Pre-designed siRNA Set A contains three designed siRNAs for PTTG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTX3 Human Pre-designed siRNA Set A contains three designed siRNAs for PTX3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTX4 Human Pre-designed siRNA Set A contains three designed siRNAs for PTX4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PU-WS13 is a selective Grp94 inhibitor, with an EC50 of 0.22 μM.

PU-WS13 is a selective Grp94 inhibitor, with an EC50 of 0.22 μM.

PU-WS13 is a selective Grp94 inhibitor, with an EC50 of 0.22 μM.

PU-WS13 is a selective Grp94 inhibitor, with an EC50 of 0.22 μM.

PUDP Human Pre-designed siRNA Set A contains three designed siRNAs for PUDP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PUF60 Human Pre-designed siRNA Set A contains three designed siRNAs for PUF60 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pulegone-d8 is deuterated labeled Tetracycline (HY-A0107). Tetracycline is a broad-spectrum antibiotic with oral activity. Tetracycline exhibits activity against a wide range of bacteria including gram-positive, gram-negative bacteria, chlamydiae, mycoplasmas and rickettsiae. Tetracycline can be used for the research of infections[1].

PUM1 Human Pre-designed siRNA Set A contains three designed siRNAs for PUM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PUM2 Human Pre-designed siRNA Set A contains three designed siRNAs for PUM2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PUM3 Human Pre-designed siRNA Set A contains three designed siRNAs for PUM3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PURA Human Pre-designed siRNA Set A contains three designed siRNAs for PURA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PURB Human Pre-designed siRNA Set A contains three designed siRNAs for PURB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PURG Human Pre-designed siRNA Set A contains three designed siRNAs for PURG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PUS1 Human Pre-designed siRNA Set A contains three designed siRNAs for PUS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PUS10 Human Pre-designed siRNA Set A contains three designed siRNAs for PUS10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PUS3 Human Pre-designed siRNA Set A contains three designed siRNAs for PUS3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PUS7 Human Pre-designed siRNA Set A contains three designed siRNAs for PUS7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PUSL1 Human Pre-designed siRNA Set A contains three designed siRNAs for PUSL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PVALB Human Pre-designed siRNA Set A contains three designed siRNAs for PVALB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PVR Human Pre-designed siRNA Set A contains three designed siRNAs for PVR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PVRIG Human Pre-designed siRNA Set A contains three designed siRNAs for PVRIG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PWP1 Human Pre-designed siRNA Set A contains three designed siRNAs for PWP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PWP2 Human Pre-designed siRNA Set A contains three designed siRNAs for PWP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PWWP2A Human Pre-designed siRNA Set A contains three designed siRNAs for PWWP2A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PXB17 can inhibit CSF1R (IC50 = 1.7 nM) by blocking the activation of PI3K/ AKT/mTORC1 signaling. PXB17 is orally effective. PXB17 significantly inhibits the growth of CRC, improves PD-1 mAb efficacy and reduces tumor recurrence in CRC[1].

PXDC1 Human Pre-designed siRNA Set A contains three designed siRNAs for PXDC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PXDN Human Pre-designed siRNA Set A contains three designed siRNAs for PXDN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PXDNL Human Pre-designed siRNA Set A contains three designed siRNAs for PXDNL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PXK Human Pre-designed siRNA Set A contains three designed siRNAs for PXK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PXMP2 Human Pre-designed siRNA Set A contains three designed siRNAs for PXMP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PXMP4 Human Pre-designed siRNA Set A contains three designed siRNAs for PXMP4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PXN Human Pre-designed siRNA Set A contains three designed siRNAs for PXN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PYCARD Human Pre-designed siRNA Set A contains three designed siRNAs for PYCARD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.